Description

Piperazine, 1-[[3-Methyl-4-(1-Methylethyl)-5-Oxo-2(5H)-Isoxazolyl]Carbonyl]-4-Phenyl- (9Ci) is a specialized heterocyclic organic compound that serves as a crucial advanced pharmaceutical intermediate and building block in synthetic chemistry. Its complex molecular architecture, featuring fused piperazine and isoxazolone rings, makes it a valuable precursor for the development of novel active pharmaceutical ingredients (APIs) and fine chemicals. This high-purity compound is primarily utilized by research institutions and pharmaceutical manufacturers engaged in drug discovery and process development.

Application

• Pharmaceutical Intermediate: Key building block in the synthesis of novel drug candidates, particularly in central nervous system (CNS) and anti-infective therapeutic areas.
• Organic Synthesis Reagent: Used in research laboratories for constructing complex heterocyclic frameworks and exploring new chemical entities.
• Agrochemical Research: Potential intermediate in the development of new-generation pesticides and herbicides due to its bioactive scaffold.
• Material Science: Investigated as a monomer or precursor for specialty polymers and functional materials with specific thermal or optical properties.
• Contract Research & Development (CRO/CDMO): Supplied to organizations conducting custom synthesis and process optimization for client projects.

Basic Information

Item	Details
Product Name	Piperazine, 1-[[3-Methyl-4-(1-Methylethyl)-5-Oxo-2(5H)-Isoxazolyl]Carbonyl]-4-Phenyl- (9Ci)
CAS No.	706804-19-5
Molecular Formula	C19H23N3O3
Molecular Weight	341.41 g/mol
Synonyms	1-[(3-Methyl-4-isopropyl-5-oxo-4,5-dihydroisoxazol-2-yl)carbonyl]-4-phenylpiperazine; 4-Phenyl-1-{[3-methyl-4-(propan-2-yl)-5-oxo-4,5-dihydro-1,2-oxazol-2-yl]carbonyl}piperazine; 1-({3-Methyl-4-[(1-methylethyl)-5-oxo-2(5H)-isoxazolyl]}carbonyl)-4-phenylpiperazine; Piperazine derivative (CAS 706804-19-5); 2-[(4-Phenylpiperazin-1-yl)carbonyl]-3-methyl-4-isopropyl-5H-isoxazol-5-one
EINECS	Contact for details

Quality Control

Our production of this high-value intermediate adheres to strict quality management systems, ensuring batch-to-batch consistency and purity. Quality is verified through comprehensive analytical techniques including HPLC, GC, NMR, and mass spectrometry. A detailed Certificate of Analysis (COA) is provided with each shipment, documenting identity, purity, and impurity profiles. We support compliance with cGMP and ICH Q7 guidelines for pharmaceutical intermediates.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). Keep the container tightly sealed in a dry environment to prevent moisture absorption. Store away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.